Johnson & Johnson Expands Partnership With HHS to Find Coronavirus Treatment
February 18 2020 - 10:16AM
Dow Jones News
By Dave Sebastian
Johnson & Johnson said it will work with the Rega Institute
for Medical Research in Belgium to identify antiviral, therapeutic
candidates to treat the disease caused by the novel coronavirus, in
an expanded effort with the Department of Health and Human
Services.
Janssen Pharmaceutical Cos., a J&J company, and the
department's Biomedical Advanced Research and Development Authority
will share costs in discovering the treatment, the company said
Tuesday.
J&J last week said it will work with HHS to accelerate the
development of a potential coronavirus vaccine.
J&J shares rose 0.2%.
Write to Dave Sebastian at dave.sebastian@wsj.com
(END) Dow Jones Newswires
February 18, 2020 10:01 ET (15:01 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Sep 2023 to Sep 2024
